$MAZE SEC Filings

This letter agreement (this “Agreement”) confirms the agreement of Maze Therapeutics, Inc., a Delaware corporation (the “Company”), and the holders of the shares of the Company’s common stock, par value $0.001 per share (the “Common Stoc...

Received 16,141 shares by exercise or conversion ($168K) · Sold 16,141 shares ($435K)

Sold 34,501 shares ($932K)

Received 7,500 shares by exercise or conversion ($78.2K) · Sold 7,500 shares ($203K)

Sold 9,705 shares ($255K)

Sold 5,106 shares ($135K) · Sold 5,189 shares ($135K)

Sold 3,191 shares ($84.5K) · Sold 3,243 shares ($84.4K)

Sold 1,981 shares ($52.4K) · Sold 2,012 shares ($52.3K)

Sold 11,227 shares ($297K) · Sold 11,411 shares ($297K)

Received 11,000 shares by exercise or conversion

Received 12,500 shares by exercise or conversion

Sold 34,501 shares ($907K) · Received 50,000 shares by exercise or conversion

Received 36,141 shares by exercise or conversion · Sold 16,141 shares ($426K)